Bioinformatic Analysis for Mucoepidermoid and Adenoid Cystic Carcinoma of Therapeutic Targets

被引:2
作者
Monserrat Ramirez-Martinez, Carla [1 ]
Fernando Jacinto-Aleman, Luis [1 ]
Pablo Cruz-Hervert, Luis [2 ]
Portilla-Robertson, Javier [1 ]
Rosa Leyva-Huerta, Elba [1 ]
机构
[1] Univ Nacl Autonoma Mexico, Dent Sch, Oral Med & Pathol Dept, Postgrad & Res Div, Mexico City 04510, DF, Mexico
[2] Univ Nacl Autonoma Mexico, Dent Sch, Orthodont Dept, Postgrad & Res Div, Mexico City 04510, DF, Mexico
关键词
adenoid cystic carcinoma; mucoepidermoid carcinoma; salivary gland; gene expression and bioinformatics; SALIVARY-GLAND CARCINOMAS; HEAD; NECK; EXPRESSION; PATHOLOGY; SURVIVAL; TUMORS;
D O I
10.3390/vaccines10091557
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Salivary gland neoplasms are a heterogeneous neoplasm group, including mucoepidermoid carcinoma (MECa), adenoid cystic carcinoma (AdCC), and many others. Objective: We aimed to identify new critical genes of MECa and AdCC using bioinformatics analysis. Methods: Gene expression profile of GSE153283 was analyzed by the GEO2R online tool to use the DAVID software for their subsequent enrichment. Protein-protein interactions (PPI) were visualized using String. Cytoscape with MCODE plugin followed by Kaplan-Meier online for overall survival analysis were performed. Results: 97 upregulated genes were identified for MECa and 86 for AdCC. PPI analysis revealed 22 genes for MECa and 63 for AdCC that were validated by Kaplan-Meier that showed FN1 and SPP1 for MECa, and EGF and ERBB2 for AdCC as more significant candidate genes for each neoplasm. Conclusion: With bioinformatics methods, we identify upregulated genes in MECa and AdCC. The resulting candidate genes as possible therapeutic targets were FN1, SPP1, EGF, and ERBB2, and all those genes had been tested as a target in other neoplasm kinds but not salivary gland neoplasm. The bioinformatic evidence is a solid strategy to select them for more extensive research with clinical impact.
引用
收藏
页数:11
相关论文
共 40 条
[1]  
[Anonymous], 2022, KM PLOTTER
[2]  
[Anonymous], 2022, DAVID BIOINFORMATICS
[3]   Management and outcome of patients with malignant salivary gland tumors [J].
Bell, RB ;
Dierks, EJ ;
Homer, L ;
Potter, BE .
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2005, 63 (07) :917-928
[4]   Osteopontin expression in salivary gland carcinomas [J].
Bjorndal, Kristine ;
Larsen, Stine R. ;
Godballe, Christian ;
Krogdahl, Annelise .
JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2011, 40 (06) :451-455
[5]   The CRTC1-MAML2 fusion is the major oncogenic driver in mucoepidermoid carcinoma [J].
Chen, Zirong ;
Ni, Wei ;
Li, Jian-Liang ;
Lin, Shuibin ;
Zhou, Xin ;
Sun, Yuping ;
Li, Jennifer W. ;
Leon, Marino E. ;
Hurtado, Maria D. ;
Zolotukhin, Sergei ;
Liu, Chen ;
Lu, Jianrong ;
Griffin, James D. ;
Kaye, Frederic J. ;
Wu, Lizi .
JCI INSIGHT, 2021, 6 (07)
[6]   Mucoepidermoid carcinoma: a five-decade journey [J].
Chenevert, Jacinthe ;
Barnes, Leon E. ;
Chiosea, Simion I. .
VIRCHOWS ARCHIV, 2011, 458 (02) :133-140
[7]   The Position of EGF Deprivation in the Management of Advanced Non-Small Cell Lung Cancer [J].
Crombet Ramos, Tania ;
Santos Morales, Orestes ;
Dy, Grace K. ;
Leon Monzon, Kalet ;
Lage Davila, Agustin .
FRONTIERS IN ONCOLOGY, 2021, 11
[8]  
Cytoscape, 2022, CYTOSCAPE
[9]   Fibronectin: Molecular Structure, Fibrillar Structure and Mechanochemical Signaling [J].
Dalton, Caleb J. ;
Lemmon, Christopher A. .
CELLS, 2021, 10 (09)
[10]   INCIDENCE AND CLINICAL RELEVANCE OF T(11;19) TRANSLOCATION IN SALIVARY GLAND MUCOEPIDERMOID CARCINOMA [J].
Dimitrijevic, Ivana Ilic ;
Loening, Thomas ;
Falk, Marcus ;
Konstantinovic, Vitomir S. ;
Vukadinovic, Miroslav ;
Tepavcevic, Zvezdana ;
Tabakovic, Sasa ;
Pejcic, Natasa ;
Milicic, Biljana ;
Milasin, Jelena .
GENETIKA-BELGRADE, 2014, 46 (02) :601-610